May 11, 2015 10:48 am EDT Acasti Receives Extension to Regain Compliance With NASDAQ Minimum Bid Price Rule
Sep 29, 2014 8:00 am EDT Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results Proving Statistically Significant Improvements in Triglycerides & Non-HDL-C